Recent data indicates that retatrutide, a dual-action medication, may represent a considerable advance in weight loss . This drug combines the effects of a GLP-1 analog and a GIP agonist , possibly offering a more outcome than available solutions. Clinical assessments have demonstrated positive outcomes, including significant reductions in weight a